Nearly 25,000kg of medicinal cannabis was produced in Australia in 2022, with an almost identical amount arriving in the country from overseas, official data from the Office of Drug Control (ODC) has revealed.

Newly-released figures show the quantity of imported cannabis last year soared to 24,887kg, up 247% from 2021 when just 7,173kg was shipped to Australia.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...

Join the Conversation

1 Comment

  1. Thanks for sharing this news Steve.
    Great to see more transparency with this data.
    I believe that, generally speaking, Australian produced products aren’t competitive price-wise for global markets hence the slow down in exports. LATAM and Africa located EU-GMP facilities are offering much better pricing to the EU. I believe there is more demand than supply in Australia currently so your point is still valid Steve.